Jon Aster
5Patents
1h-index
13Co-inventors
44Inventor score
Filing activity: May 22, 2009 → Oct 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9763956B2 | Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy | Chemistry; Metallurgy | 6 | Active |
| US8623853B2 | Treatment of cancers characterized by chromosomal rearrangement of the NUT gene | Physics | 0 | Active |
| US8716233B2 | NOTCH mutations leading to increased receptor signaling | Physics | 0 | Active |
| US9683217B2 | In vitro culture conditions for T-cell acute lymphoblastic leukemia/lymphoma | Physics | 0 | Active |
| US11674950B2 | Methods determining and treating cellular resistance to ADP-rtbosylating toxin | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.